NASDAQ
Assembly Biosciences, Inc. (ASMB) has a free cash flow growth of -255.60% as of Friday, May 29, 2026. This represents a 81.16% increase compared to its 12-month average of -1356.84%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.